These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30439532)

  • 41. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
    Xue L; Zhou B; Liu X; Heung Y; Chau J; Chu E; Li S; Jiang C; Un F; Yen Y
    Cancer Res; 2007 Jan; 67(1):16-21. PubMed ID: 17210678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma.
    Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
    Cancer Lett; 2003 Feb; 190(2):233-43. PubMed ID: 12565178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.
    Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel RRM2B gene variant associated with Telbivudine-induced mitochondrial myopathy.
    Hernández-Laín A; Guerrero AM; Domínguez-González C; Fernández-Vázquez I; Maya DG; Delmiro A; Arenas J; Morales JR; Blázquez A; Moran M; Martín MA
    J Neurol Sci; 2015 Nov; 358(1-2):481-3. PubMed ID: 26359855
    [No Abstract]   [Full Text] [Related]  

  • 45. PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress.
    Kuo ML; Lee MB; Tang M; den Besten W; Hu S; Sweredoski MJ; Hess S; Chou CM; Changou CA; Su M; Jia W; Su L; Yen Y
    Sci Rep; 2016 Jan; 6():18846. PubMed ID: 26733354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
    Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
    Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
    Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
    Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p53R2 regulates thioredoxin reductase activity through interaction with TrxR2.
    Park SJ; Kim HB; Piao C; Kang MY; Park SG; Kim SW; Lee JH
    Biochem Biophys Res Commun; 2017 Jan; 482(4):706-712. PubMed ID: 27866984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ribonucleotide reductase and mitochondrial DNA synthesis.
    Thelander L
    Nat Genet; 2007 Jun; 39(6):703-4. PubMed ID: 17534360
    [No Abstract]   [Full Text] [Related]  

  • 51. Regulation of p53R2 and its role as potential target for cancer therapy.
    Wang X; Zhenchuk A; Wiman KG; Albertioni F
    Cancer Lett; 2009 Apr; 276(1):1-7. PubMed ID: 18760875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage.
    Lembo D; Donalisio M; Cornaglia M; Azzimonti B; Demurtas A; Landolfo S
    Virus Res; 2006 Dec; 122(1-2):189-93. PubMed ID: 16872707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of siRNA-mediated silencing of p53R2 gene on sensitivity of T-ALL cellsto Daunorubicin.
    Kiani Ghalesardi O; Zaker F; Ghotaslou A; Boustani H; Rezvani MR; Kiani J; Shahidi M
    Gene; 2023 Sep; 880():147622. PubMed ID: 37419428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enzymatic property analysis of p53R2 subunit of human ribonucleotide reductase.
    Yen Y; Chu B; Yen C; Shih J; Zhou B
    Adv Enzyme Regul; 2006; 46():235-47. PubMed ID: 16846634
    [No Abstract]   [Full Text] [Related]  

  • 55. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
    Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
    Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromosomal instability triggered by Rrm2b loss leads to IL-6 secretion and plasmacytic neoplasms.
    Chang L; Guo R; Huang Q; Yen Y
    Cell Rep; 2013 May; 3(5):1389-97. PubMed ID: 23643536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
    Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
    Xue L; Zhou B; Liu X; Qiu W; Jin Z; Yen Y
    Cancer Res; 2003 Mar; 63(5):980-6. PubMed ID: 12615712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neonatal multiorgan failure due to ACAD9 mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle, and renal tubules.
    Leslie N; Wang X; Peng Y; Valencia CA; Khuchua Z; Hata J; Witte D; Huang T; Bove KE
    Hum Pathol; 2016 Mar; 49():27-32. PubMed ID: 26826406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
    Matsushita S; Ikeda R; Fukushige T; Tajitsu Y; Gunshin K; Okumura H; Ushiyama M; Akiyama S; Kawai K; Takeda Y; Yamada K; Kanekura T
    J Dermatol Sci; 2012 Oct; 68(1):19-24. PubMed ID: 22902076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.